116 related articles for article (PubMed ID: 37920080)
21. Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis.
Zhou Y; Fang C; Sun Q; Dong Y
Front Genet; 2022; 13():939175. PubMed ID: 35910226
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Rheumatoid Arthritis.
Zhang S; Sun S; Zhang Y; Liu J; Wu Y; Zhang X
Biochem Genet; 2023 Dec; ():. PubMed ID: 38112894
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
24. Modification of m6A mediates tissue immune microenvironment in calcific aortic valve disease.
Chen JY; Xiong T; Sun YR; Cong J; Gong JS; Peng L; Rong YW; Wang ZY; Chang Q
Ann Transl Med; 2022 Sep; 10(17):931. PubMed ID: 36172101
[TBL] [Abstract][Full Text] [Related]
25. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.
Wang N; Xu Y; Jin L; Wang X; Wu S; Wang Y; Zhao J; Zhou F; Ge H
Dis Markers; 2022; 2022():1829528. PubMed ID: 36051357
[TBL] [Abstract][Full Text] [Related]
26. Analysis of N6-Methyladenosine RNA Methylation Regulators in Diagnosis and Distinct Molecular Subtypes of Ankylosing Spondylitis.
Zhong C; Liang JH; Chen Z; Zhong LP; Sun GD; Xie WX; Wang DP; Zhuang WD; Guo HH; Jin DX; Li YM
Dis Markers; 2022; 2022():4942599. PubMed ID: 36157216
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
28. Analyses of m6A regulatory genes and subtype classification in atrial fibrillation.
Zhao Y; Che Y; Liu Q; Zhou S; Xiao Y
Front Cell Neurosci; 2023; 17():1073538. PubMed ID: 37435047
[TBL] [Abstract][Full Text] [Related]
29. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
30. Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis.
Zhang J; Zhang Y; Wang Z; Zhao J; Li Z; Wang K; Tian L; Yao B; Wu Q; Wang T; Wang J
Front Genet; 2022; 13():1102422. PubMed ID: 36685949
[No Abstract] [Full Text] [Related]
31. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Wu J; Wang X; Li X
Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
[TBL] [Abstract][Full Text] [Related]
32. Identification and Validation of Three m6A Regulators:
Sun J; Gan L; Sun J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672827
[TBL] [Abstract][Full Text] [Related]
33. Significance of m
Xie X; Zhang Y; Yu J; Jiang F; Wu C
Front Physiol; 2022; 13():918270. PubMed ID: 36160850
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
[TBL] [Abstract][Full Text] [Related]
35. m6A Regulator-Mediated Methylation Modification Patterns and Characteristics in COVID-19 Patients.
Qing X; Chen Q; Wang K
Front Public Health; 2022; 10():914193. PubMed ID: 35655464
[TBL] [Abstract][Full Text] [Related]
36. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic signature, subtype classification, and immune infiltration of key m6A regulators in osteomyelitis patients.
Shi X; Ni H; Wu Y; Guo M; Wang B; Zhang Y; Zhang B; Xu Y
Front Genet; 2022; 13():1044264. PubMed ID: 36544487
[No Abstract] [Full Text] [Related]
38. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
39. Gene Alterations of N6-Methyladenosine (m
Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic significance of integrating m6A modification and immune microenvironment features based on bioinformatic investigation in aortic dissection.
Guo R; Dai J; Xu H; Zang S; Zhang L; Ma N; Zhang X; Zhao L; Luo H; Liu D; Zhang J
Front Cardiovasc Med; 2022; 9():948002. PubMed ID: 36105536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
